Stocksigma LogoStocksigma Logo

Arvee Laboratories India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 2,493 (+622.4% YoY | +44.7% QoQ) ■ EBITDA: 343 (+2592.3% YoY | +37.4% QoQ) ■ EBITDA Margin (%): 13.8 (+1007 bps YoY | -73 bps QoQ) ■ PAT: 256

Arvee Laboratories India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Arvee Laboratories India Ltd · Outcome · 04 Nov 2026, 12:29 am

Arvee Laboratories India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 2,493 (+622.4% YoY | +44.7% QoQ) ■ EBITDA: 343 (+2592.3% YoY | +37.4% QoQ) ■ EBITDA Margin (%): 13.8 (+1007 bps YoY | -73 bps QoQ) ■ PAT: 256 (+25207.9% YoY | +50.9% QoQ) ■ EPS (INR): 2.32 (+23100.0% YoY | +50.6% QoQ)

Original exchange filing (PDF)

More announcements from Arvee Laboratories India Ltd

All Arvee Laboratories India Ltd announcements